CD274 and non-small cell lung carcinoma: Programmed death-ligand 1 (PD-L1) expression has been reported to be a biomarker for the prediction of CPI responders in advanced melanoma, non-small-cell lung cancer, and cervical cancer (Topalian et al. 2016).